Pateclizumab

Tidak ditemukan merek terdaftar untuk zat aktif ini.

Tidak ada catatan makanan tercatat untuk zat aktif ini.

• AbciximabMODERAT

  Mengonsumsi Abciximab bersama Pateclizumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Abciximab is combined with Pateclizumab.

• AbituzumabMODERAT

  Mengonsumsi Abituzumab bersama Pateclizumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Abituzumab is combined with Pateclizumab.

• AdalimumabMODERAT

  Mengonsumsi Adalimumab bersama Pateclizumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Adalimumab is combined with Pateclizumab.

• AdecatumumabMODERAT

  Mengonsumsi Adecatumumab bersama Pateclizumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Adecatumumab is combined with Pateclizumab.

• AducanumabMODERAT

  Mengonsumsi Aducanumab bersama Pateclizumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Aducanumab is combined with Pateclizumab.

• AfelimomabMODERAT

  Mengonsumsi Afelimomab bersama Pateclizumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Afelimomab is combined with Pateclizumab.

• AlemtuzumabMODERAT

  Mengonsumsi Alemtuzumab bersama Pateclizumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Pateclizumab.

• AlirocumabMODERAT

  Mengonsumsi Alirocumab bersama Pateclizumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Alirocumab is combined with Pateclizumab.

• AmatuximabMODERAT

  Mengonsumsi Amatuximab bersama Pateclizumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Amatuximab is combined with Pateclizumab.

• AMG 108MODERAT

  Mengonsumsi AMG 108 bersama Pateclizumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when AMG 108 is combined with Pateclizumab.